Dogwood receives Nasdaq confirmation of compliance

Dogwood (DWTX) Therapeutics has received written confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2.5M. As previously disclosed, the Company received a letter on November 15, 2024 notifying the Company that its amount of stockholders’ equity had fallen below the $2.5 million minimum stockholders’ equity requirement. On December 27, 2024, it submitted to Nasdaq a plan of compliance to achieve and sustain compliance with the Minimum Equity Requirement. On February 2, 2025, the Company received a letter from Nasdaq granting it until May 14, 2025 to regain compliance with the Nasdaq Listing Rule 5550(b)(1). On April 8, 2025, the Company received a letter from Nasdaq stating that based on its Form 8-K, dated April 3, 2025, Staff has determined that the Company complies with the Listing Rule 5550(b)(1).